Pamoic Acid Sodium

Chemistry, 1 End Use API, 2 Related Intermediates

Manufacturers/Suppliers

1 Suppliers

1 Suppliers

Also known as: Nsc-49174, Nsc49174, 2-naphthoic acid,4'-methylenebis[3-hydroxy-, disodium salt, 2-naphthalenecarboxylic acid,4'-methylenebis[3-hydroxy-, disodium salt

Molecular Formula

C₂₃H₁₆NaO₆+

Molecular Weight

411.4 g/mol

InChI Key

HBDVCWCJDFMCPY-UHFFFAOYSA-N

1 2D Structure

Pamoic Acid Sodium

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

sodium;4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid

2.1.2 InChI

InChI=1S/C23H16O6.Na/c24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29;/h1-10,24-25H,11H2,(H,26,27)(H,28,29);/q;+1

2.1.3 InChI Key

HBDVCWCJDFMCPY-UHFFFAOYSA-N

2.1.4 Canonical SMILES

C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)O)O)O)C(=O)O.[Na+]

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. Nsc-49174

2. Nsc49174

3. 2-naphthoic Acid,4'-methylenebis[3-hydroxy-, Disodium Salt

4. 2-naphthalenecarboxylic Acid,4'-methylenebis[3-hydroxy-, Disodium Salt

2.3 Create Date

2006-10-25

3 Chemical and Physical Properties

Molecular Formula	C₂₃H₁₆NaO₆+
Molecular Weight	411.4 g/mol
Hydrogen Bond Donor Count	4
Hydrogen Bond Acceptor Count	6
Rotatable Bond Count	4
Exact Mass	411.08445751 g/mol
Monoisotopic Mass	411.08445751 g/mol
Topological Polar Surface Area	115 Å²
Heavy Atom Count	30
Formal Charge	1
Complexity	569
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2

List of Suppliers

Full Screen View

Reset Filter

Ask Us

Halcyon Labs Private Limited

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

India

Virtual Booth

Digital Content

Pamoic Acid

PDF Supplier PDF

URL Supplier Web Content

CAS Number

130-85-8

End Use API

In recent years, India has become a destination for pharmaceutical research because of high intellectual ...

In recent years, India has become a destination for pharmaceutical research because of high intellectual capital and competitive technical costs. Indian professionals are exploring global avenues in pharmaceutical research with a fervour never felt before. (clinical pharmacology studies) We are people with 0% tolerance for unethical conduct and 100% belief in systems, processes and compliance for our corporate divisions. We are people with passion for success and the obsession to win. We have the potential growth catalysts with the zeal to achieve the impossible. We have set new benchmarks in the industry.

ASK
US